Clinical Study of Xinmailong Injection on Reducing Cardiovascular Toxicity in Adjuvant Chemotherapy in Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Neoplasms|Cardiac Event|Chemotherapeutic Toxicity
Interventions: DRUG: Xinmailong Injection
Sponsor: Peking Union Medical College